Search
CTx-PDE6b
go.drugbank.com/drugs/DB17858InvestigationalBeing commercialied by Coave Therapeutics, it is being investigated for the treatment of retinitis pigmentosa due to _PDE6b_ gene mutations.[L46757]
Vemtoberant
go.drugbank.com/drugs/DB21607InvestigationalVemtoberant has a monoisotopic molecular weight of 619.2 Da.
Delocamten
go.drugbank.com/drugs/DB21711InvestigationalDelocamten has a monoisotopic molecular weight of 377.16 Da.
Geraniol
go.drugbank.com/drugs/DB14183ApprovedDue to its anticancer effects, geraniol has been found to be effective against a broad range of cancers including breast, lung, colon, prostate, pancreatic, skin, liver, kidney and oral cancers [A34262
Eplontersen
go.drugbank.com/drugs/DB16199ApprovedInvestigationalanalysis from the Phase 3 NEURO-TTRansform study, where a consistent improvement in the Neuropathy Impairment Score +7 (mNIS+7) and the Norfolk Quality of Life Questionnaire-Diabetic Neuropathy (Norfolk QoL-DN
Amniotic Epithelial Cells
go.drugbank.com/drugs/DB15868Investigational[A220183,T823] These cells are potential candidates for allogeneic cell therapy and regenerative medicine due to their potential for differentiation and multiplication.[A220183]
Cyamemazine
go.drugbank.com/drugs/DB09000ExperimentalCyamemazine actually behaves like an atypical antipsychotic, due to its potent anxiolytic effects (5-HT2C) and lack of extrapyramidal side effects (5-HT2A).
Alofanib
go.drugbank.com/drugs/DB20918InvestigationalAlofanib has a monoisotopic molecular weight of 413.07 Da.
Asapiprant
go.drugbank.com/drugs/DB20492InvestigationalAsapiprant has a monoisotopic molecular weight of 501.16 Da.